This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.

Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Sign In
Don’t have an account?
  • Products
  • Therapy Areas
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts
Bayer cross
BAYER FOR PROFESSIONALSYour Resource Portal
  • Ophthalmology
  • EYLEA® (aflibercept) 8 mg
  • EYLEA® (aflibercept) 2 mg
  • Oncology
  • Nubeqa® (darolutamide)
  • Xofigo®▼ (radium-223 dichloride)
  • Cardiology
  • Beyonttra®▼ (acoramidis)
  • Kerendia®▼ (finerenone)
  • Xarelto® (rivaroxaban)
  • Women's Health
  • Angeliq® (1mg estradiol hemihydrate and 2mg drospirenone)
  • Jaydess®▼ (13.5mg levonorgestrel)
  • Kyleena® (19.5mg levonorgestrel)
  • Mirena® (52mg levonorgestrel)
  • Qlaira® (estradiol valerate/dienogest)
  • Service Optimisation & Formularies
  • Risk Minimisation Materials
  • Ophthalmology
  • Oncology
  • Cardiology
  • Women's Health
  • Ophthalmology Resources
  • Oncology Resources
  • Cardiology Resources
  • Women's Health Resources
  • Ophthalmology Events & On Demand Webinars
  • Oncology Events & On Demand Webinars
  • Cardiology Events & On Demand Webinars
  • Women's Health Events & On Demand Webinars
  • Ophthalmology Learning Zone
  • Oncology Learning Zone
  • Cardiology Learning Zone
  • Women's Health Learning Zone
  • Ophthalmology Podcasts
  • Oncology Podcasts
  • Cardiology Podcasts
  • Women's Health Podcasts
closesearch
Recent Searches
      Kerendia®▼ (finerenone)
      About CKD
      MOD & MOA
      Trial Design
    • More...
    Kerendia®▼ Logo
    Kerendia®▼ (finerenone)
    About CKD
    MOD & MOA
    Trial Design
    • CONFIDENCE Data
    • Clinical Efficacy
    • Safety Profile
    • Prescribing Considerations
    • Dosing
    • 1º Care Resources
    • 2º Care Resources
    • Pharmacist Resources
    • Events & Webinars
    • Nephrology Homepage
    • Patient Support Materials
    You are now leaving BayerPro

    The contents and the policies on the website you are visiting is not controlled by the BayerPRO team.
    Do you wish to continue?

    Nephrology homepage

    Kerendia (finerenone) UK Prescribing Information

    Product-specific information

    Kerendia®▼ (finerenone)
    Product Page
    Kerendia (finerenone) UK Prescribing Information
    PP-KER-GB-0903, March 2026

    Quick Watch Webinars

    Kerendia 2025 Year-End Highlights Video
    Kerendia®▼ (finerenone)​
    Kerendia UK Prescribing Information
    RP-KER-GB-1072, December 2024
    Kerendia®▼ (finerenone)​ and the Kidneys
    Breaking Barriers in CKD Management; short video series
    Kerendia UK Prescribing Information
    PP-KER-GB-0798, February 2024
    Kerendia®▼ (finerenone) Short Videos
    Kerendia UK Prescribing Information
    PP-KER-GB-0566, March 2024

    Resources

    Kerendia Primary Care Resources Content Card
    Kerendia®▼ (finerenone) Primary Care Resources
    Access useful, downloadable nephrology resources for HCPs in primary care.
    Kerendia UK Prescribing Information
    RP-KER-GB-1106, February 2025
    Kerendia Specialist Resources Content Card
    Kerendia®▼ (finerenone) Specialists’ Resources
    Access useful, downloadable nephrology resources for specialist HCPs.
    Kerendia (finerenone) UK Prescribing Information
    RP-KER-GB-1105, January 2025

    Events & Webinars

    View more
    Kerendia®▼ (finerenone) Short Videos
    Kerendia UK Prescribing Information
    PP-KER-GB-0566, March 2024
    Kerendia®▼ (finerenone)​ and the Kidneys
    Breaking Barriers in CKD Management; short video series
    Kerendia UK Prescribing Information
    PP-KER-GB-0798, February 2024
    Chronic Kidney Disease Bitesize Videos
    Kerendia®▼ (finerenone)​
    Kerendia UK Prescribing Information
    PP-KER-GB-0565, February 2024
    Kerendia 2025 Year-End Highlights Video
    Kerendia®▼ (finerenone)​
    Kerendia UK Prescribing Information
    RP-KER-GB-1072, December 2024

    Register with BayerPRO

    To access additional resources, personalise your experience and keep up to date via electronic communications from Bayer.

     

    Don’t have an account?
    Areas of Interest
    Cardiovascular Content Card
    Cardiovascular
    Women's Health Content Card
    Women's Health
    Nephrology Content Card
    Nephrology
    Oncology Content Card
    Oncology
    Ophthalmology 1
    Ophthalmology
    Respiratory Content Card
    Respiratory